Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients-Reference-Cited by-同舟云学术

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Published:2012-02-24 Issue:7 Volume:91 Page:1051-1063
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Dufour Annika, ,Schneider Friederike,Hoster Eva,Benthaus Tobias,Ksienzyk Bianka,Schneider Stephanie,Kakadia Purvi M.,Sauerland Maria-Cristina,Berdel Wolfgang E.,Büchner Thomas,Wörmann Bernhard,Braess Jan,Subklewe Marion,Hiddemann Wolfgang,Bohlander Stefan K.,Spiekermann Karsten

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-012-1423-4.pdf

Reference47 articles.

1. Tenen DG, Hromas R, Licht JD, Zhang DE (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90(2):489–519

2. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A 94(2):569–574

3. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, Owens BM, Shigematsu H, Levantini E, Huettner CS, Lekstrom-Himes JA, Akashi K, Tenen DG (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21(6):853–863

4. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T (2005) Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 11(4):1416–1424

5. Dufour A, Schneider F, Metzeler KH, Hoster E, Schneider S, Zellmeier E, Benthaus T, Sauerland MC, Berdel WE, Buchner T, Wormann B, Braess J, Hiddemann W, Bohlander SK, Spiekermann K (2009) Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol 28(4):570–577

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia;Annals of Hematology;2024-07-18

2. Prognostic impact of CEBPA mutational subgroups in adult AML;Leukemia;2024-01-16

3. Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations;Current Hematologic Malignancy Reports;2023-06-01

4. Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia;Nature Communications;2023-04-05

5. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications;Clinical and Experimental Medicine;2022-10-13